loading...| Preferred Name |
Enalaprilat |
|
| Synonyms |
Enalaprilat Citrate, Anhydrous |
|
| Definitions |
The active metabolite of ENALAPRIL and one of the potent, intravenously administered, ANGIOTENSIN-CONVERTING ENZYME INHIBITORS. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D015773 |
|
| altLabel |
Enalaprilat Citrate, Anhydrous Xanef Enalaprilat Anhydrous Vasotec MK 422 Pres iv Enalaprilic Acid 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate L-Proline, N-((1S)-1-carboxy-3-phenylpropyl)-L-alanyl- MK-422 MK422 Enalaprilat Dihydrate Enalaprilat, (R)-Isomer, Anhydrous |
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
| cui |
C0728763 C0886808 C1569502 C4316917 C0771174 C0886809 C0886810 C0014027 C0917915 C1569503 |
|
| DC |
1 |
|
| definition |
The active metabolite of ENALAPRIL and one of the potent, intravenously administered, ANGIOTENSIN-CONVERTING ENZYME INHIBITORS. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion. |
|
| DX |
19900101 |
|
| HN |
1990 |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
GV0O7ES0R3 94133-18-3 76391-23-6 0 Q508Q118JM |
|
| isa | ||
| LT |
TRD |
|
| MDA |
19890719 |
|
| MMR |
20180521 |
|
| MN |
D12.644.456.345.360.300 |
|
| notation |
D015773 |
|
| PA |
D000959 D000806 |
|
| prefLabel |
Enalaprilat |
|
| RR |
76391-23-6 ((R)-isomer, anhydrous) 94133-18-3 (anhydrous, citrate) 84680-54-6 (Enalaprilat) 84799-87-1 (cpd w/o stereochem designation, anhydrous) Q508Q118JM |
|
| TERMUI |
T359649 T046778 T617301 T046781 T046780 T359648 T000924961 T359651 T617299 T839564 T046779 |
|
| TH |
US NLM (1999) CA NLM (1990) FDA SRS (2014) INN (19XX) DE USAN (1984) NLM (2014) NLM (2018) USP (19XX) BAN (19XX) |
|
| tui |
T109 T116 T121 |
|
| subClassOf |